 intranas butyl patient perenni rhiniti efficaci safeti studi nasal biopsi fluocortin butyl fcb topic intranas corticosteroid powder symptom sign perenni rhiniti previou short-term studi multicent open-label studi efficaci safeti fcb treatment period patient perenni rhiniti treatment inhal fcb nostril time day total dosag mg/day subsequ month third patient dosag mg/day third dosag mg/day third patient dosag mg/day patient studi patient month treatment symptom sign score evalu score baselin improv studi period month patient substanti control symptom specimen nasal biopsi begin end treatment decreas eosinophil cellular infiltr slight tendenc increas mast cell count trend normal nasal mucosa advers effect mean plasma cortisol level normal corticotropin stimul baselin month fcb therapi